The global cilastatin sodium market size was accounted for USD 806 million in 2020 and expected to grow at a significant CAGR of 3.1% during the forecast period 2021 to 2027 and projected to reach over USD 990 million by 2027. The increasing incidence of lower respiratory tract infections is a primary factor to drive the market growth.
On the basis of clinical application, the segment is divided into lower respiratory tract infections, urinary tract infections, and other applications. The lower respiratory tract infection segment held the largest market share in 2020. As per a research study shared by WHO, 1.4 million people die each year due to tuberculosis across the globe.
The report titled “Cilastatin Sodium Market – Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast – 2020 – 2027″ offers a holistic view of the Cilastatin Sodium industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global Cilastatin Sodium market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.
Browse Full report on Global Cilastatin Sodium Market report at https://www.researchcorridor.com/cilastatin-sodium-market/
The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.
North America is currently dominating the geography segment for cilastatin sodium market growth. Rising prevalence of urinary tract infection primarily drives the market growth in the region. As per the latest research citings presented by the National Institute of Health (NIH), approximately 40% of the women population in the United States are suffering with urinary tract infection. Furthermore, nurturing regulatory environment provided by the USFDA for the sale and distribution of cilastatin sodium combination products further accentuates the market growth in the region.
Cilastatin Sodium Market report summarizes the positive growth rate in upcoming years, and market size with competitive analysis. Our experts have analyzed the historical data to compare with the current market scenario to calculate the market growth in the coming years. The study provides an exhaustive report that includes an executive summary, scope, and forecast of the market.
The Cilastatin Sodium Market Segmentation:
By Clinical Application:
By Distribution Channel:
To know more about the study, make an inquiry before purchase @ https://www.researchcorridor.com/inquiry/?id=135551
Pharmaceutical manufacturers actively engaged in the production of cilastatin sodium are Fresenius Kabi., Pfizer, Inc., Sandoz, Inc., Merck KGaA, Enzo Life Sciences, Inc., Taiwan Biotech., Teva Pharmaceutical Industries Limited, Mylan Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Ltd., and Sun Pharmaceutical Industries Ltd.
Key Questions Answered by Cilastatin Sodium Market Report:
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=135551
Other Related Reports:
Research Corridor is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities to optimize strategies. Our expert’s team of analysts’ provides enterprises with strategic insights. Research Corridor works to help enterprises grow through strategic insights and actionable solutions. Feel free to contact us for any report customization at firstname.lastname@example.org.
Our Blog: http://www.reportsstack.com/